Drug Utilization Study Evaluating Additional Risk Minimisation Measures for Upadacitinib in the Treatment of Ulcerative Colitis in Europe

ENCePP Seal

This study has been awarded the ENCePP seal

Conflicts of interest of investigators

DeclarationofInterests-Annex5_P24-344 upa UC DUSRMM_231219_JR

Composition of steering group and observers

EUPAS107885-108467

Data sources

• Data source(s):
  Danish registries (access/analysis)

  National Prescribed Drugs Register / Läkemedelsregistret
• Data source(s), other:
  SWIBREG Sweden, SMINET Sweden, Swedish national registers, ENEIDA Spain
• Data sources (types):
  Administrative data (e.g. claims)

  Disease registry

  Other
• Data sources (types), other:
  Pharmacy dispensing records, Quality register, medical chart abstraction

Use of a Common Data Model (CDM)

• CDM mapping:
  No

Data quality specifications

• Check conformance:
  Unknown
• Check completeness:
  Unknown
• Check stability:
  Unknown
• Check logical consistency:
  Unknown

Data characterisation

• Data characterisation conducted:
  No